Mopidamol in non-small cell lung cancer: Anti-oncogene or accident?

Robert B. Livingston

doi:10.1093/jnci/80.2.77

Mopidamol in non-small cell lung cancer: Anti-oncogene or accident?

Robert B. Livingston

Cancer Center

Research output: Contribution to journal › Editorial › peer-review

6 Scopus citations

Original language	English (US)
Pages (from-to)	77-78
Number of pages	2
Journal	Journal of the National Cancer Institute
Volume	80
Issue number	2
DOIs	https://doi.org/10.1093/jnci/80.2.77
State	Published - Mar 16 1988

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1093/jnci/80.2.77

Cite this

@article{bc78d47768764e479061d00826f99c41,

title = "Mopidamol in non-small cell lung cancer: Anti-oncogene or accident?",

author = "Livingston, {Robert B.}",

year = "1988",

month = mar,

day = "16",

doi = "10.1093/jnci/80.2.77",

language = "English (US)",

volume = "80",

pages = "77--78",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - Mopidamol in non-small cell lung cancer

T2 - Anti-oncogene or accident?

AU - Livingston, Robert B.

PY - 1988/3/16

Y1 - 1988/3/16

UR - http://www.scopus.com/inward/record.url?scp=0023786484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023786484&partnerID=8YFLogxK

U2 - 10.1093/jnci/80.2.77

DO - 10.1093/jnci/80.2.77

M3 - Editorial

C2 - 2830406

AN - SCOPUS:0023786484

SN - 0027-8874

VL - 80

SP - 77

EP - 78

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

IS - 2

ER -

Mopidamol in non-small cell lung cancer: Anti-oncogene or accident?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this